Pharmacology

OnabotulinumtoxinA for Bladder Problems; Older Cancer Patients Not Getting Full Treatment; Vitamin B Reduces Diabetic Neuropathy

OnabotulinumtoxinA is thought of mostly as a treatment for facial wrinkles, but it's also approved for other medical conditions, including cervical dystonia; chronic migraine; and now, overactive bladder (OAB), a condition in which the bladder squeezes too often or without warning. OnabotulinumtoxinA, injected into the bladder, blocks the transmission of nerve impulses to the bladder muscle, calming contractions, which helps increase the bladder's storage capacity. It also reduces episodes of urinary incontinence.


 

Recommended Reading

Oncologist Communication Feedback Improves Patient Trust
Federal Practitioner
A Brighter Prognosis in Nonalcoholic Fatty Liver Disease
Federal Practitioner
Posterior Reversible Encephalopathy Syndrome as a Complication of Chemotherapy
Federal Practitioner
CLEOPATRA Study and MBC
Federal Practitioner
Diabetes May Increase Risk of Cancer Death
Federal Practitioner
Clinical Trial List for Cancer
Federal Practitioner
Burn Scar Carcinoma: Patients With Marjolin's Ulcer
Federal Practitioner
Evaluation of Vitamin D Supplementation in a Veteran Population
Federal Practitioner
Vitamin D Deficiency
Federal Practitioner
Venous Thromboembolism and Weight Changes in Veteran Patients Using Megestrol Acetate as an Appetite Stimulant
Federal Practitioner